1. EUFOREA treatment algorithm for allergic rhinitis
- Author
-
Hellings, P. W., Scadding, G., Bachert, C., Bjermer, L., Canonica, G. W., Cardell, L. O., Carney, A. S., Constantinidis, J., Deneyer, L., Diamant, Z., Durham, S., Gevaert, P., Harvey, R., Hopkins, C., Kjeldsen, A., Klimek, L., Lund, V. J., Price, D., Rimmer, J., Ryan, D., Roberts, G., Sahlstrand-Johnson, P., Salmi, S., Samji, M., Scadding, Guy, Smith, P., Steinsvik, A., Wagenmann, M., Seys, S., Wahn, U., Fokkens, W. J., Ear, Nose and Throat, and AII - Inflammatory diseases
- Subjects
Otorhinolaryngology ,Humans ,General Medicine ,Rhinitis, Allergic ,Algorithms ,Asthma - Abstract
Allergic rhinitis (AR) is the most common chronic inflammatory disease, affecting an estimated 100 million Europeans (1). Despite a substantial burden on individuals, society and health economies (2), AR remains under-diagnosed, under-estimated (in terms of severity), and under-treated (3). Although effective and safe treatments exist, patients wait too long to seek medical advice, often preferring to self-manage at drug stores and at the pharmacy (4).
- Published
- 2020